TCM

TCG Crossover Management Portfolio holdings

AUM $876M
1-Year Est. Return 23.66%
This Quarter Est. Return
1 Year Est. Return
+23.66%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.18B
AUM Growth
+$221M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
38
New
Increased
Reduced
Closed

Top Buys

1
+$48.8M
2
+$32.7M
3
+$18.7M
4
MBX
MBX Biosciences
MBX
+$16.9M
5
GPCR icon
Structure Therapeutics
GPCR
+$16.2M

Top Sells

1
+$41.8M
2
+$10.7M
3
+$8.66M
4
CCCC icon
C4 Therapeutics
CCCC
+$5.9M
5
SLN
Silence Therapeutics
SLN
+$4.76M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$138M 11.73%
3,670,206
2
$95.2M 8.07%
2,650,150
3
$75.2M 6.37%
6,964,375
4
$69.8M 5.91%
6,056,596
5
$56.4M 4.78%
2,112,984
-159,744
6
$55.2M 4.67%
3,033,560
-261,790
7
$52.4M 4.44%
12,362,205
8
$51.1M 4.33%
879,344
9
$48.8M 4.14%
+2,427,138
10
$46.8M 3.96%
1,989,103
11
$46.7M 3.95%
1,063,000
+368,453
12
$46.3M 3.92%
5,319,148
13
$46.2M 3.92%
2,890,816
14
$38M 3.22%
1,477,593
15
$32.7M 2.77%
+2,415,000
16
$30.4M 2.58%
2,761,861
17
$29.9M 2.53%
2,470,265
-714,920
18
$27.8M 2.36%
1,423,642
19
$27.8M 2.35%
550,000
20
$24.3M 2.06%
3,858,000
21
$23.9M 2.03%
486,957
22
$18.7M 1.59%
+5,250,000
23
$16.9M 1.43%
+650,000
24
$15M 1.27%
+4,643,812
25
$14.1M 1.19%
2,008,339
-1
1
2